Johnson & Johnson Highlights New Scientific Evidence and Reinforces its Leadership with Portfolio Advancements at AF Symposium
February 03, 2026
February 03, 2026
NEW BRUNSWICK, New Jersey, Feb. 3 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:
* * *
Johnson & Johnson Highlights New Scientific Evidence and Reinforces its Leadership with Portfolio Advancements at AF Symposium
*
Irvine, CA - February 3, 2026 - Johnson & Johnson is announcing new portfolio innovations in addition to compelling clinical evidence in atrial fibrillation (AFib) at the 31 st A . . .
* * *
Johnson & Johnson Highlights New Scientific Evidence and Reinforces its Leadership with Portfolio Advancements at AF Symposium
*
Irvine, CA - February 3, 2026 - Johnson & Johnson is announcing new portfolio innovations in addition to compelling clinical evidence in atrial fibrillation (AFib) at the 31 st A . . .
